Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| 1 |
Amazon
AMZN
|
+$597M |
| 2 |
Meta Platforms (Facebook)
META
|
+$497M |
| 3 |
Otis Worldwide
OTIS
|
+$377M |
| 4 |
T-Mobile US
TMUS
|
+$333M |
| 5 |
AbbVie
ABBV
|
+$312M |
Top Sells
| 1 |
AGN
Allergan plc
AGN
|
+$878M |
| 2 |
RTN
Raytheon Company
RTN
|
+$537M |
| 3 |
Apple
AAPL
|
+$457M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$427M |
| 5 |
Accenture
ACN
|
+$245M |
Sector Composition
| 1 | Technology | 23.73% |
| 2 | Healthcare | 14.52% |
| 3 | Financials | 12.98% |
| 4 | Consumer Discretionary | 10.98% |
| 5 | Communication Services | 9.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
VEDL
3151
DELISTED
Vedanta Limited American Depostary Shares (Each representing four equity shares)
VEDL
| $933K | ﹤0.01% |
166,327
+128,728
| +342% | +$722K |
|
3152
Canadian Solar
CSIQ
$725M
| $931K | ﹤0.01% |
48,339
-555
| -1% | -$10.7K |
|
3153
Stagwell
STGW
$1.43B
| $931K | ﹤0.01% |
447,972
-334,404
| -43% | -$695K |
|
|
ESTE
3154
DELISTED
Earthstone Energy Inc. Class A Common Stock
ESTE
| $923K | ﹤0.01% |
325,333
+41,735
| +15% | +$118K |
|
3155
Actinium Pharmaceuticals
ATNM
$51.2M
| $918K | ﹤0.01% |
87,113
+67,000
| +333% | +$706K |
|
|
LX
3156
LexinFintech Holdings
LX
$974M
| $917K | ﹤0.01% |
86,250
+9,091
| +12% | +$96.7K |
|
|
IMDX
3157
Insight Molecular Diagnostics Inc. Common Stock
IMDX
$91.9M
| $912K | ﹤0.01% |
23,879
+7,511
| +46% | +$287K |
|
3158
Tecnoglass
TGLS
$3.47B
| $907K | ﹤0.01% |
166,463
+14,755
| +10% | +$80.4K |
|
|
MBII
3159
DELISTED
Marrone Bio Innovations, Inc.
MBII
| $904K | ﹤0.01% |
772,830
+181,865
| +31% | +$213K |
|
|
MITT
3160
AG Mortgage Investment Trust
MITT
$246M
| $900K | ﹤0.01% |
94,067
-58,933
| -39% | -$564K |
|
3161
United Security Bancshares
UBFO
$167M
| $900K | ﹤0.01% |
134,619
+6,402
| +5% | +$42.8K |
|
3162
Target Hospitality
TH
$877M
| $899K | ﹤0.01% |
532,081
+30,672
| +6% | +$51.8K |
|
|
TTOO
3163
DELISTED
T2 Biosystems, Inc
TTOO
| $899K | ﹤0.01% |
142
-10
| -7% | -$63.3K |
|
|
TLND
3164
DELISTED
Talend S.A. American Depositary Shares
TLND
| $898K | ﹤0.01% |
25,919
+546
| +2% | +$18.9K |
|
3165
Transcontinental Realty Investors
TCI
$400M
| $895K | ﹤0.01% |
29,820
+4,248
| +17% | +$127K |
|
3166
Afya
AFYA
$1.41B
| $891K | ﹤0.01% |
38,038
+13,747
| +57% | +$322K |
|
3167
Colony Bankcorp
CBAN
$299M
| $890K | ﹤0.01% |
75,651
+2,245
| +3% | +$26.4K |
|
3168
Lineage Cell Therapeutics
LCTX
$295M
| $888K | ﹤0.01% |
1,021,544
-655,975
| -39% | -$570K |
|
3169
Stantec
STN
$12.7B
| $885K | ﹤0.01% |
28,679
-115
| -0.4% | -$3.55K |
|
3170
Provident Financial
PROV
$104M
| $883K | ﹤0.01% |
65,853
+4,483
| +7% | +$60.1K |
|
3171
Champions Oncology
CSBR
$88M
| $879K | ﹤0.01% |
92,004
+48,269
| +110% | +$461K |
|
|
UROV
3172
DELISTED
Urovant Sciences Ltd.
UROV
| $878K | ﹤0.01% |
89,246
+6,875
| +8% | +$67.6K |
|
|
MJCO
3173
DELISTED
Majesco
MJCO
| $877K | ﹤0.01% |
111,594
+304
| +0.3% | +$2.39K |
|
3174
Takeda Pharmaceutical
TAK
$48.4B
| $873K | ﹤0.01% |
48,742
+16,877
| +53% | +$302K |
|
3175
Hovnanian Enterprises
HOV
$909M
| $872K | ﹤0.01% |
37,298
| – | – |
|